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Introduction: Pluripotent stem cells are increasingly used to build therapeutic models, including the
transplantation of neural progenitors derived from human embryonic stem cells (hESCs). Recently, long non-coding
RNAs (lncRNAs), including delta-like homolog 1 gene and the type III iodothyronine deiodinase gene (DLK1-DIO3)
imprinted locus-derived maternally expressed gene 3 (MEG3), were found to be expressed during neural
development. The deregulation of these lncRNAs is associated with various neurological diseases. The
imprinted locus DLK1-DIO3 encodes abundant non-coding RNAs (ncRNAs) that are regulated by differential
methylation of the locus. We aim to study the correlation between the DLK1-DIO3-derived ncRNAs and the
capacity of hESCs to differentiate into neural lineages.
Methods: We classified hESC sublines into MEG3-ON and MEG3-OFF based on the expression levels of MEG3
and its downstream microRNAs as detected by quantitative reverse transcription-polymerase chain reaction
(qRT-PCR). A cDNA microarray was used to analyze the gene expression profiles of hESCs. To investigate the
capacity of neural differentiation in MEG3-ON and MEG3-OFF hESCs, we performed neural lineage differentiation
followed by neural lineage marker expression and neurite formation analyses via qRT-PCR and immunocytochemistry,
respectively. MEG3-knockdown via small interfering RNA (siRNA) and small hairpin RNA (shRNA) was used to investigate
the potential causative effect of MEG3 in regulating neural lineage-related gene expression.
Results: DLK1-DIO3-derived ncRNAs were repressed in MEG3-OFF hESCs compared with those in the MEG3-ON hESCs.
The transcriptome profile indicated that many genes related to nervous system development and neural-type tumors
were differentially expressed in MEG3-OFF hESCs. Three independent MEG3-knockdown assays using different
siRNA and shRNA constructs consistently resulted in downregulation of some neural lineage genes. Lower expression
levels of stage-specific neural lineage markers and reduced neurite formation were observed in neural lineage-like cells
derived from MEG3-OFF-associated hESCs compared with those in the MEG3-ON groups at the same time points after
differentiation.
Conclusions: Repression of ncRNAs derived from the DLK1-DIO3 imprinted locus is associated with reduced neural
lineage differentiation potential in hESCs.* Correspondence: hfchen@ntu.edu.tw; shaupinglin@ntu.edu.tw
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Pluripotent stem cells are increasingly used for therapeutic
models, including the transplantation of neural progeni-
tors derived from human embryonic stem cells (hESCs)
[1]. Pluripotent stem cells represent a potential therapy
for neurological disorders [2]. Improving the effective-
ness of hESC-derived neural precursor transplantation
therapies has been widely studied [3]. However, teratoma
or tumor formation after transplantation remains a major
safety concern [4]. Long non-coding RNAs (lncRNAs),
defined as longer than 200 nucleotides in length, are
suggested to be involved in neural developmental events
[5,6] and in neurological degenerative diseases [7,8]. Thus,
lncRNAs may play important roles in deriving neural
lineage cells from hESCs.
Recently, abundant expression of an lncRNA, mater-
nally expressed gene 3 (Meg3), which is also called gene
trap locus 2 (Gtl2), was detected in the mouse nervous
system. Meg3 is expressed in the forebrain in both devel-
oping and adult mice [9] as well as in developing corti-
cospinal neurons [10]. This lncRNA is derived from the
delta-like homolog 1 gene and the type III iodothyronine
deiodinase gene (Dlk1-Dio3) imprinted locus, which ex-
presses many non-coding RNAs (ncRNAs) from the ma-
ternal chromosome, including the lncRNAs Meg3/MEG3,
Rian/MEG8, and Mirg; one C/D box small nucleolar RNA
gene cluster; and microRNA (miRNA) clusters. In con-
trast, three protein-coding genes, Dlk1, Rtl1, and Dio3, are
expressed from the paternal chromosome. The correct ex-
pression dosages of these ncRNAs and genes are regulated
by the two differentially methylated regions of the locus,
including the intergenic differentially methylated region
(IG-DMR) and the Meg3/MEG3 DMR [11-13]. Differen-
tial methylation of this imprinted locus is required for
maintaining the full developmental potential of mouse-
induced pluripotent stem cells (miPSCs) [14-16].
Humans possessing imprinting defects in the DLK1-
DIO3 locus suffer from skeletal malformations, develop-
mental delay/mental retardation, tumor development, and
even postnatal death [17-24]. Moreover, ncRNAs derived
from the DLK1-DIO3 locus are associated with neuro-
developmental and neurodegenerative disorders. For
example, more than 85% of DLK1-DIO3 locus-derived
miRNAs are downregulated in patients with schizo-
phrenia [25], and decreased lncRNA MEG3 expres-
sion occurs in patients with Huntington’s disease [7].
Recently, DLK1-DIO3 locus-derived lncRNAs were
suggested to associate with polycomb repressive com-
plex 2 (PRC2) and to affect genome-wide PRC2 tar-
gets in trans in mouse embryonic stem cells (mESCs)
and human induced pluripotent stem cells (hiPSCs)
[26]. PRC2 introduces the specific repressive histone
marker H3K27me3 to target regions and suppresses
gene expression [27,28]. Most PRC2 target genes areknown for their important roles in developmental
processes [28].
To study the correlations between the DLK1-DIO3-de-
rived ncRNAs and the differentiation capacity of hESCs
toward neural lineages, we classified hESCs into MEG3-
ON and MEG3-OFF on the basis of the expression of
MEG3 and its downstream miRNAs. We found that
using hESCs with repressed DLK1-DIO3-derived ncRNA
expression for neural lineage differentiation produced
reduced neural lineage marker expression at different
stages and reduced neurite formation.
Materials and methods
Ethics statement
This study included the use of human pluripotent stem
cells. The derivation of these cell lines and their use in
this particular study were approved by the ethics com-
mittee of National Taiwan University Hospital and the
Internal Research Board of Academia Sinica. Written in-
formed consent was obtained from all subjects involved
in this study.
Human embryonic stem cell culture
The NTU1, NTU3, and H9 hESC lines [29-31] and
hiPSC lines [32,33] were used in this study. These pluri-
potent stem cells were maintained on murine embryonic
fibroblast (MEF) feeders by using serum-free medium
(ReproCELL primate and human ESC culture medium;
ReproCELL, Kanagawa, Japan). The hESCs were pas-
saged once per week by using a 30-gauge insulin needle
or using dispase and collagenase type IV (Gibco, part of
Invitrogen, Carlsbad, CA, USA). At 48 hours after passa-
ging, hESC colonies were observed. The medium was
refreshed every day. For embryoid body (EB) formation,
the hESCs were cultured in suspension in Petri dishes
for 5 or 12 days, in accordance with a previously pub-
lished protocol [29]. On days 5 and 12, EBs were col-
lected for quantitative reverse transcription-polymerase
chain reaction (qRT-PCR). The diameters of EBs were
quantified by using QCapture Pro 6.0 software (QImaging,
Surrey, BC, Canada).
Quantitative reverse transcription-polymerase chain
reaction for long non-coding RNA and mRNA
qRT-PCR was used to quantify relative mRNA levels in
the undifferentiated hESCs, EBs, and neural lineage-like
cells. Briefly, at a predetermined time point, cells were
collected and treated with TRIzol® (Invitrogen) to extract
RNA, and samples of cDNA were obtained by using ran-
dom hexamer primers following the Superscript III kit
protocol (Invitrogen). We detected the expression levels
of MEG3 and MEG8 in hESCs by using the SYBR Green
PCR master mix (Kapa Biosystems, Wilmington, MA,
USA). PCR was performed in a thermal cycler (LightCycler®
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the following program: 50°C for 2 minutes, 95°C for
10 minutes, and 45 cycles of denaturation at 95°C
for 15 seconds and annealing and extension at 60°C for
45 seconds. The quantitation of the endoderm, meso-
derm, and ectoderm layer-specific transcripts, SOX17,
HAND1, and PAX6, respectively, were measured during
EB formation by qRT-PCR. The expression levels of
neural lineage differentiation-associated genes, which
included PAX6, RTN1, DLK1, SOX11, beta-III TUBULIN,
and MAP2, were detected in MEG3-ON and MEG3-OFF
hESCs and their differentiated neural lineage-like cells
by using the SYBR Green PCR master mix (Kapa Biosys-
tems). The housekeeping gene GAPDH was used as a
normalization control. The 2−ΔΔCp method was used to
quantify the qRT-PCR results. The primer sequences
are listed in Additional file 1: Table S1. qRT-PCR results
demonstrating consistently detectable and specific sig-
nals were presented in the bar charts and subject to stat-
istical analysis. N.D. (not detectable) indicates that the
expression of a particular gene in certain samples, if
any, was below the sensitivity threshold of qRT-PCR
analysis.
Quantitative reverse transcription-polymerase chain
reaction for microRNA
The UPL probe system (Roche) was used to detect the ex-
pression of miRNAs, including miR-127-3p, miR-376c,
miR-494, miR-495, miR-496, and miR-154. The miRNA
detection protocol was based on a previous protocol [34].
PCR was performed in a thermal cycler (LightCycler® 480
II Instrument; Roche). Briefly, a sequence-specific RT
primer was used for cDNA synthesis of a specific
miRNA in the RT step. Next, a sequence-specific for-
ward primer, a universal reverse primer, and UPL probe
21 were used for amplifying the cDNA. RNU48 was
used as an internal control to normalize the miRNA ex-
pression levels. The 2−ΔΔCp method was used to quantify
the qRT-PCR results. The primer sequences are listed in
Additional file 1: Table S1.
Microarray analysis
Sample preparation
We collected and classified NTU1 hESCs into four
MEG3-ON sublines (NTU 1–1, 1–2, 1–3 and 1–4) and
five MEG3-OFF sublines (NTU 1–5, 1–6, 1–7, 1–8, and
1–9) on the basis of the MEG3 expression levels deter-
mined by qRT-PCR. We also validated the methylation
patterns of the DLK1-DIO3 locus by bisulfite sequencing.
H9 hESCs and EBs were used as positive and negative
controls of pluripotency, respectively, for the PluriTest
assay but were not used for identifying genes with differ-
ential expression between the MEG3-ON and MEG3-OFF
groups.RNA isolation and hybridization
Total RNA was extracted by using TRIzol® reagent
(Invitrogen) and purified by using RNeasy® mini kits
(Qiagen, Venlo, Limburg, The Netherlands) to obtain 2 μg
of RNA. Concentration and quality were assessed by using
an electrophoresis bioanalyzer instrument (Agilent
Technologies, Santa Clara, CA, USA). The HumanHT-12
version 4.0 Expression BeadChip (Illumina, San Diego,
CA, USA) was used on the basis of its up-to-date con-
tent derived from the National Center for Biotechnology
Information Reference Sequence (NCBI RefSeq) database
(Build 36.2, Release 22). Biotin-labeled cRNA prepared
from 1.5 μg of RNA from each sample was fragmented,
hybridized to individual HT-12 version 4.0 Expression
BeadChips by using the direct hybridization assay proto-
col, and scanned by using a BeadArray Reader (Illumina).
Identification of differentially expressed genes
Raw idat microarray files were read into Partek Genomics
Suite version 6.5 (Partek, St. Louis, MO, USA) to generate
log transformation and quantile normalization. Quality as-
sessment for each array data was also validated by using
Partek or R through data distribution and principal com-
ponent analysis of samples. In total, 47,319 of the 48,206
probe sets were mapped to 21,777 genes, and 14,235 genes
had more than one representative probe set. For each re-
dundancy, the probe set with the greatest average expres-
sion across all samples was chosen to represent each gene.
To identify the most significantly differentially expressed
genes (DEGs) between MEG3-ON and MEG3-OFF hESCs,
we selected only the DEGs identified by the following
criterion: (i) genes with more than 1.5 times fold change
between MEG3-ON and MEG3-OFF and with significant
differential expression value (P <0.05) based on Welch’s t
test (307 genes). (ii) We used the same package in the Bio-
conductor software package [35] to perform significance
analysis of microarray (SAM) [36] analysis for compari-
sons between two groups (MEG3-ON and MEG3-OFF)
with 1,000 permutations. In total, 314 significant genes
with false discovery rate (FDR) of less than 0.05 and d of
1.68 were selected.
On the basis of these criteria, among the two gene lists
from Welch’s t test (307 genes) and SAM (314 genes),
we obtained 114 intersection DEGs for further biological
and functional analysis. A hierarchical clustering heat-
map of the 114 genes was generated by using ggplot2
[37] packages in the R platform and Euclidean distance
and average linkage.
Gene Ontology analysis, gene set enrichment assay, and
‘PluriTest’
We used MetaCore™ software (version 6.18, build 65505)
from GeneGo (part of Thomson Reuters, New York, NY,
USA) to investigate whether the genes showing differential
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are involved in particular biological processes or diseases.
The MetaCore Gene Ontology (GO) biological process or
GO disease analysis used the hypergeometric test to select
GO biological process gene sets or disease biomarkers
enriched in genes that displayed significant differential
expression. The P value was calculated by using the
right-tailed Fisher’s exact test based on the hypergeo-
metric distribution. The corrected P values were obtained
by FDR calculation based on the Benjamini-Hochberg
method [38] of accounting for multiple testing. A back-
ground gene list was collected from all 21,777 mapped
microarray genes.
Gene Set Enrichment Analysis (GSEA) [39,40] was
performed to determine whether the gene expression
levels annotated by the GO term (GO:0007399) associ-
ated with nervous system development were specifically
enriched in the MEG3-ON (NTU 1–1, 1–2, 1–3, and 1–4)
or MEG3-OFF (NTU 1–5, 1–6, 1–7, 1–8, and 1–9)
hESCs; gene sets were identified in which these genes
were enriched, together with an associated P value calcu-
lated by permutation testing. Partial genes from the gene
sets were listed in the results. FDR and familywise-error
rate (FWER) statistical calculations were performed as de-
scribed by Subramanian et al. [40]. Moreover, the hESC
gene sets [41] were adopted to test whether the gene sets
associated with ESCs could be enriched in the differential
expression profiles of the MEG3-ON and MEG3-OFF
groups.
Furthermore, a separate ‘PluriTest’ [42] was applied to
evaluate whether the samples possessed or lost pluripo-
tent features by using machine-learning methods. The
pluripotency score is a logistic regression model that en-
ables a probability-based choice between the pluripotent
and non-pluripotent phenotypic classes based on micro-
array data. Overall, 12 microarray chips were analyzed in
this test—four MEG3-ON hESCs (NTU 1–1, 1–2, 1–3,
and 1–4), seven MEG3-OFF hESCs (NTU 1–5, 1–6, 1–7,
1–8, and 1–9), and two H9 hESCs as the pluripotent con-
trols—and one EB was the pluripotency negative control
for the PluriTest. The data were deposited in the NCBI
Gene Expression Omnibus (GEO) and are accessible
through GEO Series accession number GSE58809.
Neural lineage differentiation
hESC maintenance and EB formation were described
above in the ‘Human embryonic stem cell culture’ section.
For neuroectodermal sphere (NES) formation, 4-day-old
EBs were cultured in N2 medium containing Dulbecco’s
modified Eagle’s medium/F12, NEAA (1X), L-glutamine
(2 mM), N2 supplement (1X), sodium pyruvate (1 mM),
and basic fibroblast growth factor (20 ng/mL) (Gibco) for
3 days, followed by Matrigel attachment for 3 or 18 days.
Half of the N2 medium was refreshed every 48 hours.Immunocytochemistry
Cell differentiation was performed in eight-well chamber
slides (Millicell EZ slide; Millipore, Billerica, MA, USA).
Cells were fixed with 4% paraformaldehyde for 20 mi-
nutes and blocked with 2% bovine serum albumin
(BSA)/0.1% Triton X-100 in 1X phosphate-buffered sa-
line (PBS) for 5 to 10 minutes. The cells were incubated
with primary antibodies at 4°C for 16 hours in PBS contain-
ing 2% BSA. The cells were washed and then incubated
with fluorescent secondary antibodies (715-485-150 and
711-485-152; Jackson ImmunoResearch, West Grove,
PA, USA) for 1 hour. Immunocytochemistry was also
performed by using anti-β-III tubulin (MAB1637;
Millipore), anti-MAP2 (GTX111679; GeneTex, Irvine, CA,
USA), and anti-Ki67 (ab15580; Abcam, Cambridge, UK)
antibodies.
Bisulfite-sequencing analysis
Bisulfite modification was performed by using an EZ
DNA Methylation Kit (Zymo Research, Irvine, CA,
USA) with genomic DNA extracted from hESCs of dif-
ferent passage numbers. PCR amplification was initiated
at 95°C for 5 minutes, followed by 40 cycles of 95°C for
30 seconds, 54°C for 45 seconds, and 72°C for 30 seconds.
The following primer sequences were adopted from previ-
ous reports: H19 and KvDMR [43,44], IG-DMR and
MEG3 DMR [19], and PEG10 DMR [45]. The amplified
products were cloned into the pGEM-T Easy vector
(Promega, Madison, WI, USA), and 20 clones from
each genomic sample were picked for sequencing. The
sequences were analyzed by BiQ Analyzer software [46],
and only non-clonal sequences are presented.
Infection of human embryonic stem cells with small
interfering RNA and small hairpin RNA lentiviruses
Two knockdown construct types were used in this study.
(i) Two MEG3-siRNA plasmids with different target
sequences and scramble siRNA-GFP plasmids (Abcam
Company). The MEG3-siRNA plasmids and their target
sequences for MEG3 are as follows: MEG3-451 siRNA-
GFP: tgtgttcacctgctagcaaactggagtgt; MEG3-512-siRNA-
GFP: actgactctgtcatcacccttatgatgtc. (ii) MEG3-shRNA
plasmid with the other target sequence and the scrambled
shRNA plasmid (OriGene TR30021). The shRNA plasmid
and its target sequences for MEG3 are as follows: TL
320132C MEG3: gagaggttgtttcactggtatctattgca.
Packaging, envelope, and siRNA or shRNA plasmids
were transfected into 293 T cells to produce lentiviral
particles. Harvested media containing lentivirus were
concentrated and used to infect hESCs. The following
two infection methods were used in these experiments:
(i) Harvested media with lentivirus-containing siRNA
plasmid were used to infect hESC clumps (50 to 250
cells per clump). (ii) Harvested media with lentivirus-
Figure 1 (See legend on next page.)
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Figure 1 Classification of MEG3-ON and MEG3-OFF human embryonic stem cells (hESCs) by detecting the expression of the DLK1-DIO3
locus-derived non-coding RNAs (ncRNAs). (A) The DLK1-DIO3 imprinted locus, which is highly conserved between mice and humans,
including clusters of maternally expressed functional ncRNAs, which are marked in red. The human homologs of the Gtl2 and Rian mice genes
are MEG3 and MEG8, respectively. Lollipops with closed circles represent methylated CpG regions, and open circles represent unmethylated CpG
regions. Mat, maternal chromosome; Pat, paternal chromosome. (B) The hESCs with high expression levels of imprinted long non-coding RNAs
(lncRNAs) (MEG3 and MEG8) and of several imprinted microRNAs (miRNAs) from the DLK1-DIO3 locus (miR-127-3p, miR-154, miR-376c, miR-495,
miR-494, and miR-496) were classified as MEG3-ON hESCs. The hESCs without detectable MEG3 expression accompanied by significant repression
of other ncRNAs from the same locus were classified as MEG3-OFF hESCs. GAPDH was used as an internal control for mRNA expression analysis,
and RNU48 was used as an internal control for miRNA expression analysis. The quantitation of lncRNA and miRNA expression was performed by
using the 2−ΔΔCp method. Error bars represent the standard error of the mean generated from three biological repeats. **P <0.01 with respective
MEG3-ON groups by Student’s t test. DLK1-DIO3, delta-like homolog 1 gene and the type III iodothyronine deiodinase gene; Gtl2, gene trap locus
2; IG-DMR, intergenic differentially methylated region; MEG3, maternally expressed gene 3; N.D., not detectable.
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infection.
The infected hESCs were cultured on feeder cells for
4 days and switched to ESC medium containing puro-
mycin (1 μg/mL) for selection. Antibiotic-selected and
GFP-positive hESCs were amplified and harvested for
qRT-PCR detection.
Statistics
In most of the experiments using the NTU1 and NTU3
hESC lines, the error bars represent the standard error
of the mean (SEM) generated from three biological sam-
ples with three technical repeats each. In the experiments
using the H9 hESC and hiPSC lines, the error bars repre-
sent the SEM generated from one biological sample with
three technical repeats. In the MEG3-shRNA knockdown
experiments, the error bars represent the SEM generated
from one biological sample, with three technical repeats
each. Student’s t test was used for calculating P values.
*P <0.05 or **P <0.01 was considered to be significant.
In the MEG3-siRNA knockdown experiments, the error
bars represent the SEM generated from one biological
sample with three technical repeats. For multiple-group
analysis in the MEG3-siRNA knockdown experiments,
we used one-way analysis of variance followed by Dunnett’s
multiple comparisons test and statistics via GraphPad
Prism 6 software (GraphPad Software, Inc., La Jolla, CA,
USA). Significance was assigned at *P <0.05 and **P <0.01.
The data analysis for the arrays is described in the
‘Microarray analysis’ subsection.
Results
MEG3-OFF human embryonic stem cells have significantly
repressed expression of DLK1-DIO3-derived long
non-coding RNAs and microRNAs
The DLK1-DIO3 imprinted locus is highly conserved
between mice and humans (Figure 1A). In this study,
we observed that the DLK1-DIO3 imprinted locus was
much more susceptible to hypermethylation than other
imprinted loci in both hESC lines and hiPSC lines
(Additional file 2: Figure S1). Our miRNA expressionprofile, which was analyzed by using the Nanostring
nCounter™ analysis system (Human miRNA Panel version
2) [47], further confirmed that 37 out of 39 of the most
significantly downregulated miRNAs in later-passage
hESCs were derived from the DLK1-DIO3 locus (Additional
file 3: Table S2). We collected hESCs and detected their
expression levels of DLK1-DIO3-derived ncRNAs, including
two lncRNAs, MEG3 (Gtl2 in mice) and MEG8 (Rian
in mice), and several miRNAs from different regions of
this locus (Figure 1A). Based on the qRT-PCR results,
the hESCs with higher MEG3 and MEG8 expression were
classified as MEG3-ON hESCs, in which several miRNAs
from this locus, miR-127-3p, miR-154, miR-376c, miR-494,
miR-495, and miR-496, were also abundantly expressed
(Figure 1B). In contrast, hESCs sublines in whichMEG3 ex-
pression was below the detection threshold of qRT-PCR
platform, accompanied by significantly reduced expression
of downstream MEG8 and miRNAs, were classified as
MEG3-OFF hESCs (Figure 1B). The pluripotency pro-
files displayed no significant differences in pluripotency-
associated gene expression levels between these two
hESC sublines on the basis of both GSEA and ‘PluriTest’
(Additional file 4: Figure S2). Thus, MEG3-ON and
MEG3-OFF hESC sublines can serve as a paired study
model to illuminate the potential role of DLK1-DIO3-
derived ncRNAs in hESC-associated research and pre-
clinical model.Embryoid bodies derived from MEG3-OFF human
embryonic stem cells showed unusual morphologies and
decreased expression of the ectodermal and neural stem
cell marker PAX6
To investigate theMEG3-ON andMEG3-OFF hESC differ-
entiation capacities, we began by directly differentiating
MEG3-ON and MEG3-OFF NTU1 hESCs into EBs. No
obvious morphological differences were observed between
the undifferentiated MEG3-ON and MEG3-OFF hESCs
or between their respective 5-day-old EB derivatives
(Figure 2A). However, in prolonged culture up to day 12
after EB formation, the EBs derived from MEG3-OFF
Figure 2 (See legend on next page.)
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Figure 2 Twelve-day-old embryoid bodies (EBs) differentiated from MEG3-OFF human embryonic stem cells (hESCs) displayed
abnormal morphologies and expression levels of developmentally regulated genes. (A) Day 12 EBs that were differentiated from MEG3-OFF
NTU1 hESCs were smaller and not well bordered in structure than EBs differentiated from MEG3-ON NTU1 hESCs. Scale bars, 1,000 μm. The bar
chart illustrated the differences in diameters of the 12-day-old EBs derived from MEG3-ON and MEG3-OFF hESC sublines. Error bars represent the
standard error of the mean (SEM) generated from three biological samples with 20 to 40 EBs in each group. **P <0.01 with respective MEG3-ON
groups by Student’s t test. (B) Day 12 EBs differentiated from MEG3-OFF hESCs displayed unusual expression levels of developmentally regulated
genes, including higher expression levels of endoderm- and mesoderm-related genes (SOX17 and HAND1, respectively) and low but detectable
expression levels of an ectoderm-related gene (PAX6). ‘d’ represents the day of EB formation. GAPDH was used as an internal control for mRNA
expression analysis. The quantitation of mRNA expression was performed by using the 2−ΔΔCp method. Error bars represent the SEM generated
from three biological samples with three technical repeats each. **P <0.01 compared with the corresponding MEG3-ON groups by Student’s
t test. MEG3, maternally expressed gene 3.
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these EBs were not well bordered (Figure 2A).
Moreover, specific markers from the three embryonic
germ layers were differentially expressed in 12-day-old EBs
(Figure 2B). In MEG3-OFF EBs, the endoderm-specific
marker SOX17 and the mesoderm-specific marker HAND1
were overexpressed, whereas the ectoderm-specific marker
PAX6, which is also a neural stem cell marker, was only
weakly expressed, which may reduce the neural differenti-
ation potential or other differentiation abnormality from
MEG3-OFF hESC sublines.
Undifferentiated MEG3-OFF human embryonic stem cells
(hESCs) displayed a different transcriptome profile from
MEG3-ON hESCs, particularly in the neural lineage-related
gene subset
To further investigate the cellular properties of MEG3-
ON and MEG3-OFF hESCs, we conducted a transcrip-
tome analysis by using cDNA microarrays. We generated
a hierarchical clustering heatmap of the 114 genes with
significant differential expression between undifferentiated
MEG3-ON and MEG3-OFF hESCs. These 114 DEGs were
the intersection of the two gene lists analyzed by
Welch’s t test (gene selection criteria: P value <0.05 and a
fold change >1.5) and by SAM (gene selection criterion:
FDR <0.05) (Figure 3A). To further examine whether
these DEGs were related to neural lineages, MetaCore GO
biological process and GO disease analysis were used to
analyze the 114 DEGs. Through the GO biological process
analysis, many of the DEGs were classified as develop-
mentally regulated genes belonging to neural lineage
differentiation, including genes associated with ‘gener-
ation of neurons (GO:0048699; FDR = 1.608 × 10−8)’, ‘neuro-
genesis (GO:0022008; FDR = 1.608 × 10−8)’, ‘axonogenesis
(GO:0007409; FDR = 1.95 × 10−8)’, and ‘neuron differenti-
ation (GO:0030182; FDR = 1.217 × 10−8)’ (Figure 3B, left
panel). Through the GO disease analysis, deregulation of
these DEGs was correlated with many tumor types, and
most of these DEGs were neural lineage-associated
tumors (Figure 3B, right panel). In addition, a partial sub-
set of genes classified as ‘nervous system development
(GO:0007399; FDR = 0.014, familywise-error rate <0.001)’by GSEA also showed significant differential expression
patterns between the MEG3-ON and MEG3-OFF hESCs
(Figure 3C). Among these genes, PAX6 and RTN1 are
known for their functions as a neural stem cell marker
and as a neuronal differentiation-related gene [48], re-
spectively (Figure 3C).
We validated the association between the levels of
MEG3 expression and PAX6 and RTN1 expression by
qRT-PCR analysis in paired sublines of three independent
hESC lines or in two iPSC lines. The results indicated that
PAX6 and RTN1 displayed reduced expression in each
type of MEG3-OFF human pluripotent stem cell line with
repressed MEG3 expression (Figure 4A). Moreover, when
MEG3 expression was reduced in NTU1 hESCs by knock-
down via either shRNA or siRNA, PAX6 and RTN1 were
also downregulated (Figure 4B), suggesting that MEG3
may directly or indirectly regulate the expression of these
genes in hESCs.
Intriguingly, the DLK1 gene, which is a paternally
expressed gene from the same imprinted locus, also
showed decreased expression in pluripotent stem cells
with repressed MEG3 expression, in contrast to the ex-
pected reciprocal regulation of these two genes (Figure 4A).
A DLK1 function related to neural lineage differentiation
was recently observed in mouse and human ESCs [49].
Notably, DLK1 was also downregulated in two out of three
independent MEG3 knockdown lines: one si-MEG3 line
and one sh-MEG3 line (Figure 4B). When the two si-
MEG3-treated hESC lines were compared, the cell line as-
sociated with reduced DLK1 expression was shown to be
associated with obvious further PAX6 downregulation,
suggesting that DLK1 deregulation may be one of the rea-
sons for the reduced expression of these neural lineage-
promoting genes (PAX6 and RTN1) in undifferentiated
hESCs.
MEG3 may be directly involved in regulating PRC2
target genes [26], which are often developmentally regu-
lated. Some of the neural progenitor markers, PAX6,
CXCR4, and SOX21, which were differentially expressed
between MEG3-ON and MEG3-OFF NTU1 hESCs, were
also PRC2 targets subject to EZH2- and SUZ12-mediated
H3K27me3 modification [50,51] (Additional file 5: Figure S3).
Figure 3 MEG3-OFF human embryonic stem cells (hESCs) displayed different transcriptome profiles, particularly in genes related
to neural lineage. (A) In total, 114 genes displayed significant differential expression between MEG3-ON and MEG3-OFF hESCs. The
embryoid body (EB) sample differentiated from ‘MEG3-ON’ hESCs was used as a reference for differentiated hESCs. The heatmap represents
the most significant differentially expressed genes selected by the intersection indicated by Welch’s t test (P <0.05; fold change >1.5) and
significance analysis of microarrays (SAM) (false discovery rate <0.05). The heatmap displays differentially expressed genes that can be used
to distinguish between the MEG3-ON and MEG3-OFF cell states. The green-to-red colors of the heatmap are linearly mapped to the Z-scores,
which range from −3 to 3. (B) MEG3-ON and MEG3-OFF hESCs showed differences in the expression levels of many genes that correlate with
neural lineage development and with different tumor types. This analysis was performed by using MetaCore software (GeneGo), which includes
developmental processes 1,317 Gene Ontology (GO) terms in Biological Process for GO process testing and literature-based biomarkers of
clinical diseases for GO disease testing. (C) A partial gene list of subset of genes related to ‘nervous system development (GO:0007399)’ was
clearly shown to be differentially expressed between undifferentiated MEG3-ON and MEG3-OFF hESCs by using GSEA. In this heatmap, expression
values are represented as colors, with the range of colors (red, pink, light blue, and dark blue) indicating the range of expression values
(high, moderate, low, and lowest, respectively). MEG3, maternally expressed gene 3.
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Figure 4 Associations between the expression of MEG3 and neural lineage genes in human embryonic stem cell (hESC) and human
induced pluripotent stem cell (hiPSC) lines. (A) Repression of MEG3 was consistently correlated with downregulation of PAX6, RTN1, and DLK1
in various cell lines. The cell lines where MEG3 was not detectable, including NTU1, NTU3, H9, and iPSC lines, also displayed lower expression
levels of PAX6, RTN1, and DLK1. The mRNA expression was quantified with the 2−ΔΔCp method (using GAPDH for normalization). In the NTU1 and
NTU3 hESC lines, error bars represent the standard error of the mean (SEM) generated from three biological repeats. In the H9 hESC line and the
two iPSC lines, error bars represent the SEM generated from one biological sample with three technical repeats. *P <0.05, **P <0.01 with the
corresponding MEG3-ON groups by Student’s t test. N.D., not detectable. (B) MEG3 knockdown assays were conducted via small hairpin RNA
(shRNA) and small interfering RNA (siRNA) to examine the association between MEG3 reduction and the expression levels of neural lineage-related
genes in NTU1 hESCs. In the sh-MEG3 group with MEG3 reduction, PAX6, RTN1, and DLK1 showed downregulated expression (upper panel) compared
with the scramble control. PAX6 and RTN1 were also downregulated in two si-MEG3-treated groups with reduced MEG3 expression, whereas DLK1 was
reduced in one siRNA-treated group compared with the scramble control (lower panel). The mRNA expression was quantified with the 2−ΔΔCp method
(using GAPDH for normalization). Error bars represent the SEM generated from one biological sample with three technical repeats each. *P <0.05, **P
<0.01 with the corresponding scramble control groups by Student’s t test in shRNA experiments; one-way analysis of variance and Dunnett’s
multiple comparisons test were used in siRNA experiments, with significance defined as *P <0.05 and **P <0.01. MEG3, maternally expressed
gene 3.
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related genes through a PRC2-mediated mechanism
in hESCs.
MEG3-OFF human embryonic stem cell-derived neural
lineage-like cells showed lower expression levels of neural
lineage markers and reduced neurite formation
Next, we examined the potential function of ncRNAs
derived from the DLK1-DIO3 imprinted locus in neural
lineage differentiation in hESCs. We performed in vitro
neural lineage differentiation with NTU1 and NTU3 hESC
lines (Figure 5A) and investigated the expression levels of
several lineage-specific markers, including PAX6, RTN1,
SOX11 [52], beta-III Tubulin, and MAP2 [53]. At both the
EB and the NES stage, the neural stem cell and progenitor
cell marker PAX6 was expressed at lower levels in the
MEG3-OFF hESC-derived cells (Figure 5B). After 3 days
of differentiation on Matrigel, the neuronal precursor and
immature neuron marker SOX11 and RTN1 that encodes
the neuronal differentiation marker RTN-1C were also
expressed at dramatically lower levels in the differentiated
cells derived from MEG3-OFF hESCs (Figure 5B). After
18 days of Matrigel attachment, the neuronal and neurite
markers beta-III Tubulin, MAP2, and RTN1 were signifi-
cantly downregulated in the neural lineage-like cells de-
rived from MEG3-OFF hESCs (Figure 5B). Most of these
neural progenitor and neuronal markers were expressed
at low but detectable levels in MEG3-OFF hESC-derived
cells throughout the differentiation process (Additional
file 6: Figure S4). This finding also raised the possibility
that the neural lineage differentiation rate of MEG3-OFF
hESCs might be slower than that of normal hESCs. Fur-
thermore, we analyzed neurite formation capacity by
staining with anti-beta-III Tubulin and MAP2 antibodies
after 18 days of differentiation on Matrigel (Figure 6).
Neural lineage-like cells derived from MEG3-ON hESCs
displayed obvious neurite formation at this stage. MEG3-
OFF hESC-derived neural lineage-like cells displayedcomparatively reduced neurite formation at the same
stage, although some cells were positively stained for
beta-III Tubulin and MAP2 (Figure 6A and 6B). The
percentage of beta-III Tubulin-positive or MAP2-positive
cells differentiated fromMEG3-OFF hESCs was significantly
lower than those from the MEG3-ON hESCs (Additional
file 7: Figure S5). The numbers of Ki67-positive-stained
cells were not obviously different between the MEG3-
ON and MEG3-OFF hESC-derived cells, suggesting
those observed differentiation defects seemed not to be
linked to the change in cellular proliferation (Additional
file 8: Figure S6). Collectively, all of these results sug-
gested that the MEG3-ON hESCs with active expression
of ncRNAs derived from the DLK1-DIO3 imprinted
locus were associated with a better capacity for neural
lineage differentiation.
Discussion
Selecting high-quality hESC lines has been one of the
key issues for stem cell-associated studies and therapies.
Imprinting instability has long been a problem for med-
ical applications of pluripotent stem cells, including de-
velopmental potential and the risk of cancer formation.
The maintenance of differential methylation of the
DMRs of imprinted loci is required for the correct dos-
age of imprinted gene expression, which is suggested to
be crucial for ESC function [54,55]. Accumulating evi-
dence suggests that proper imprinting marks on the
mouse Dlk1-Dio3 locus are important for the biological
functions of miPSCs. Aberrant hypermethylation of the
Dlk1-Dio3 locus has been related to the impaired devel-
opmental potential of miPSCs. According to the reports
by Stadtfeld et al. [15,16] and by Liu et al. [14], Meg3off
miPSCs with an aberrantly hypermethylated Dlk1-Dio3
locus and repressed miRNAs could not achieve full de-
velopmental potential for generating full-term mice in a
tetraploid complementation assay [14-16]. Ascorbic acid
(vitamin C) has been shown to preserve a stable
Figure 5 (See legend on next page.)
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Figure 5 Neural markers were differentially expressed between MEG3-ON and MEG3-OFF human embryonic stem cell
(hESC)-differentiated cells during neural lineage differentiation. (A) Neural lineage differentiation was conducted from the undifferentiated
stage to the 18 day-Matrigel attachment stage in NTU1 and NTU3 hESC lines. (B) Expression levels of stage-specific markers were analyzed by
quantitative reverse transcription-polymerase chain reaction in MEG3-ON and MEG3-OFF groups during differentiation. The quantitation of mRNA
expression was performed by using the 2−ΔΔCp method (using the housekeeping gene GAPDH for normalization). Error bars represent the standard
error of the mean generated from three biological samples with three technical repeats each. *P <0.05, **P <0.01 compared with the respective
MEG3-ON groups by Student’s t test. MEG3, maternally expressed gene 3; NES, neuroectodermal sphere.
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somatic cell reprogramming for producing miPSC lines,
thereby increasing the success rate of embryos reaching
full-term development after tetraploid complementation
[16]. These studies indicated that ncRNAs derived from
the Dlk1-Dio3 locus are required for developmental po-
tential in mouse pluripotent stem cells. Moreover, a study
by Stadtfeld et al. demonstrated that the head tissues of
Meg3off embryos derived from a tetraploid complementa-
tion assay with Meg3off miPSCs displayed dramatic repres-
sion of three important neural lineage genes, Pax6, Mash-
1, and Hes-5. Their data suggested a possible correlation
between the ncRNAs derived from the DLK1-DIO3
imprinted locus and the expression levels of neural lineage
genes. In the present study, we revealed a positive associ-
ation between the activities of the DLK1-DIO3 imprinted
locus and the differentiation capacity of hESCs for neural
lineages on the basis of the following observations: (i) The
MEG3-OFF hESCs had reduced potential for differentiat-
ing into normal EBs, as evidenced by impaired morpholo-
gies and by reduced expression of the ectodermal marker
PAX6. (ii) Many genes involved in nervous system devel-
opment were differentially expressed between MEG3-ON
and MEG3-OFF undifferentiated hESCs. (iii) Neural
lineage-like cells derived from MEG3-OFF hESCs showed
downregulation of neural lineage markers and reduced
neurite formation compared with the MEG3-ON groups.
None of the above-mentioned studies can exclude the
possibility that unidentified genomic regions other than
DLK1-DIO3 imprinted locus also acquire aberrant epi-
genetic marks during iPSC reprogramming or in vitro
ESC culture, which accumulatively or independently cause
the functional deficiency of these MEG3-OFF-associated
pluripotent stem cells. Our MEG3 knockdown experi-
ments induced downregulation of neural lineage markers,
suggesting a certain level of potential causative effect
between MEG3 expression level and the developmental
potential of hESCs.
MEG3 and DLK1 have been observed to be recipro-
cally regulated in mouse embryos [11]. However, how
these two genes are regulated in mouse and human
pluripotent stem cells is not fully understood. Even in
mESC lines in which Meg3 is highly expressed, the ex-
pression patterns of Dlk1 are extremely variable [15].
Based on array data, both Meg3 and Dlk1 were shown tobe abundantly expressed in one mESC line; however, in
three other mESC lines with Meg3 expression, the Dlk1
expression level was shown to be lower [15]. Moreover,
Dlk1 expression has also been shown to be low in Meg3off
miPSC lines [15]. In regard to the expression of DLK1 in
hESC lines, the array data from another study demon-
strated that it was downregulated in most of the tested
MEG3-OFF hESC lines [56]. These data imply that the cell
type-specific and stage-specific developmental regulation
may be the primary factor that controls the net expression
level of DLK1 in undifferentiated hESCs. Kaneko et al. did
not observe reciprocal correlation of MEG3 and DLK1
expression levels between undifferentiated MEG3+ and
MEG3− hiPSCs identified in their study. They also did
not find the differential PRC2 binding on the DLK1 pro-
moter when overexpressing MEG3 in hiPSCs [26]. A
DLK1 function related to neural lineage differentiation
was recently observed in mESCs and hESCs. DLK1-over-
expressing mESCs and hESCs have been shown to pro-
mote increased neurogenesis in mESC-derived neural
progenitors and hESC-derived neural progenitors, respect-
ively [49]. Interestingly, in our study, the MEG3-ON
hESCs with increased capacity for neural lineage differen-
tiation displayed relatively higher DLK1 expression levels
compared with the MEG3-OFF hESCs. Our study is the
first to link these associations between MEG3 and DLK1
expression with the capacity for neural lineage differenti-
ation in hESCs.
Although MEG3 and DLK1 are reciprocally regulated
in E16.6 full mouse embryos by parental origin-specific
methylation of their imprinting control region [11], in
many mouse pluripotent stem cell lines and hESC lines,
including the cells lines in our study, lower MEG3 ex-
pression is surprisingly associated with lower expression
of DLK1. Because imprinting instability is a frequent
phenomenon in in vitro culture systems of mouse and
human pluripotent stem cells, this finding raises the
possibility that amplification of epigenetic abnormalities
might be easily observed in in vitro culture conditions.
We speculate that when maternally expressed ncRNAs
derived from the DLK1-DIO3 locus are silenced, the de-
regulation of miRNAs from the same locus might affect
other downstream factors, including certain epigenetic
modifiers. Consistent with this hypothesis, we previ-
ously detected a dramatic increase in H3K9me3 and a
Figure 6 Neurite formation was reduced in MEG3-OFF human embryonic stem cell (hESC)-differentiated cells compared with cells
differentiated from MEG3-ON hESCs. Immunofluorescent staining was performed with anti-beta-III Tubulin and anti-MAP2 antibodies to examine
neurite formation in cells derived from MEG3-ON and MEG3-OFF hESCs of the NTU1 (A) and NTU3 (B) cell lines after 18 days of differentiation on
Matrigel. Scale bars, 100 μm. MEG3, maternally expressed gene 3.
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MEG3-OFF hESCs (data not shown). These results sug-
gest that the global chromatin state in this cell type may
be more condensed, which may further affect the de-
regulation of genes related to MEG3 expression levels
found in our study, including the DLK1 gene.
The lncRNA MEG3 derived from the DLK1-DIO3 locus
possesses tumor suppressor properties in several cancer
types, many of which are associated with the nervous sys-
tem, including pituitary tumors [22], neuroblastomas [57],
meningiomas [21], and gliomas [58]. MEG3 expression is
significantly decreased in tumor tissues compared with
adjacent normal tissues. MEG3 overexpression has been
shown to promote cell apoptosis in glioma cell lines and
inhibit cell proliferation in glioma and meningioma cell
lines [21,58]. We observed that many genes related to
various cancer types, primarily those associated with the
nervous system, were deregulated in the MEG3-OFF
hESCs in which MEG3 and the other downstream ncRNAs
were repressed. Therefore, avoiding the use of MEG3-OFF
hESCs may reduce the potential risk of tumorigenesis
from stem cell-based therapies.
Notably, the RTN1 gene, which is correlated with several
neural lineage-type tumors, was dramatically downregu-
lated in MEG3-OFF hESCs and in their neural lineage-like
derivatives. The RTN1 gene encodes the RTN1C protein,
which is a marker of neuronal differentiation and is known
to be downregulated in patients with Alzheimer’s disease
and Down syndrome [48]. RTN1C can induce cell apop-
tosis in neuroectodermal tumors and may be a potential
molecular target for therapy [59]. Intriguingly, we ob-
served that RTN1 was downregulated when MEG3 was
knocked down, suggesting that MEG3 might participate in
the regulation of this gene. Additionally, because MEG3
and RTN1C can induce apoptosis in cancer cells, deter-
mining whether RTN1C is regulated by MEG3 in cancer
models may be worth further investigation.
Conclusions
For basic and preclinical research, choosing hESC lines
with higher expression levels of DLK1-DIO3 imprinted
locus-derived ncRNAs as starting materials, characterized
by the expression of the lncRNA MEG3, may benefit
studies of neural lineages. Additionally, screening for
MEG3-expressing hESCs may potentially lower the risk
of tumorigenesis in stem cell-based therapies.
Additional files
Additional file 1: Table S1. Total primer sequences used in this study.
Additional file 2: Figure S1. The DLK1-DIO3 locus was more
susceptible to hypermethylation than others in hESC and iPSC lines. (A)
The IG-DMR and MEG3 DMR of the DLK1-DIO3 imprinted locus were two
of the first DMRs to be abnormally hypermethylated in NTU1 hESCssubjected to prolonged culture (hypermethylated in the examined hESC
samples of P64) in comparison with the H19 DMR of the IGF2-H19
imprinted locus and with the PEG10 DMR and KvDMR from the other
two imprinted loci that were differentially methylated in the NTU1 hESCs.
P denotes passage numbers. Closed circles represent methylated CpG
sites, and open circles represent unmethylated CpG sites. Blue lines between
two sets of methylation patterns separate independent bisulfite-sequencing
reactions. For identical sequences that cannot be excluded as clonal
amplification, we show only one clone and indicate the number of
repeats as ‘x N’. (B) The MEG3 DMR of the DLK1-DIO3 imprinted locus
was more susceptible to hypermethylation in a cultured H9 hESC line
and in two hiPSC lines in comparison to the H19 DMR, which was previously
thought to be highly susceptible to hypermethylation in cultured
pluripotent stem cells. iPS-1 was reprogrammed from granulosa cells,
and iPS-2 was reprogrammed from foreskin fibroblasts. Closed circles
represent methylated CpG sites, and open circles represent unmethylated
CpG sites. Dotted lines between two sets of methylation patterns separate
independent bisulfite-sequencing reactions. For identical sequences that
cannot be excluded as clonal amplification, we show only one clone
and indicate the number of repeats as ‘x N’. DLK1-DIO3, delta-like homolog
1 gene and the type III iodothyronine deiodinase gene; DMR, differentially
methylated region; hESC, human embryonic stem cell; hiPSC, human induced
pluripotent stem cell; IG-DMR, intergenic differentially methylated region;
iPSC, induced pluripotent stem cell; MEG3, maternally expressed gene 3.
Additional file 3: Table S2. microRNA profiles of the early and later
passage hESCs. Among the 800 miRNAs tested, DLK1-DIO3 locus derived
miRNAs are most dramatically silenced in prolonged cultured hESCs. The
value of the two samples represents the counting frequency. DLK1-DIO3,
delta-like homolog 1 gene and the type III iodothyronine deiodinase
gene; hESC, human embryonic stem cell; miRNA, microRNA.
Additional file 4: Figure S2. No significant difference in pluripotency-
associated gene expression was observed between MEG3-ON and
MEG3-OFF hESCs. (A) No significant differences in pluripotency-related
gene expression were found based on Gene Set Enrichment Analysis
(GSEA). (B) No significant differences in pluripotency-related gene expression
were found based on ‘PluriTest’. Samples A-D consisted of MEG3-ON
undifferentiated hESCs, sample E consisted of MEG3-ON hESC-differentiated
EBs, and samples F-L consisted of undifferentiated MEG3-OFF hESCs. Samples
A-J were derived from the NTU1 hESC line; samples K-L were derived
from the H9 hESC line. The area between the red lines indicates the
range containing approximately 95% of the tested pluripotent samples.
The blue lines indicate the scores observed in approximately 95% of the
non-pluripotent samples from other studies. hESC, human embryonic
stem cell; MEG3, maternally expressed gene 3.
Additional file 5: Figure S3. MEG3 may affect the expression of certain
PRC2 target genes, including neural lineage-related genes. Significantly
differentially expressed genes were identified through significance analysis
of microarray (SAM) between MEG3-ON and MEG3-OFF hESCs (described as
Sig. genes in red). PAX6, CXCR4, and SOX21 genes were identified among
the overlapping clusters of the Sig. genes, EZH2 target genes (GSM327665,
GSM831028), SUZ12 target genes (GSM831042, GSM935352),
H3K27me3-enriched genes (GSM327663), and neural progenitor
markers. hESC, human embryonic stem cell; MEG3, maternally
expressed gene 3; PRC2, polycomb repressive complex 2.
Additional file 6: Figure S4. Most neural lineage markers were
expressed at lower levels in MEG3-OFF hESCs- derived cells throughout
differentiation. (A) Significantly higher expression levels of PAX6, RTN1,
and MAP2 were detected in NTU1 and NTU3 MEG3-ON hESC-derived cells
compared with the MEG3-OFF groups throughout the process of neural
lineage differentiation. beta-III TUBULIN was also significantly upregulated
in NTU1 cells derived from MEG3-ON hESCs compared with the MEG3-OFF
groups at the EB stage, at both 3 days and 18 days after attachment; however,
beta-III TUBULIN was upregulated in the MEG3-OFF group at the NES stage.
beta-III TUBULIN was also detected in NTU3 lines and was upregulated in
MEG3-ON groups at 18 days after attachment but not at the NES stage or at
3 days after attachment. The quantitation of mRNA expression was
performed using the 2−ΔΔCp method (using the housekeeping gene
GAPDH for normalization). Error bars represent the standard error of
the mean generated from two biological samples with three technical
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http://stemcellres.com/content/6/1/1repeats each. *P <0.05, **P <0.01 compared with the corresponding
MEG3-ON groups by Student’s t test. (B) The melting curves of PAX6 gene
that was significantly expressed at lower but detectable levels in MEG3-OFF
hESC-differentiated cells at the EB and NES stages. EB, embryoid body; hESC,
human embryonic stem cell; MEG3, maternally expressed gene 3; NES,
neuroectodermal sphere.
Additional file 7: Figure S5. Quantitation of beta-III Tubulin- or
MAP2-positive cells after differentiation from the MEG3-ON and
MEG3-OFF hESCs. The percentage of beta-III Tubulin-positive or
MAP2-positive cells differentiated from the NTU1 and NTU3 MEG3-OFF
hESCs was significantly lower than those from the MEG3-ON hESCs.
Error bars represent the standard error of the mean generated from
two biological samples with three technical repeats each. *P <0.05,
**P <0.01 compared with the corresponding MEG3-ON groups by
Student’s t test. hESC, human embryonic stem cell; MEG3, maternally
expressed gene 3.
Additional file 8: Figure S6. Ki67 staining for the MEG3-ON and
MEG3-OFF hESC-differentiated neural lineage-like cells after 18 days on
Matirgel. The numbers of Ki67-positive-stained cells were not obviously
different between the MEG3-ON and MEG3-OFF hESC-differentiated
cells, suggesting that those observed differentiation defects seemed
not to be linked to the change in cellular proliferation. Scale bars,
100 μm. hESC, human embryonic stem cell; MEG3, maternally expressed
gene 3.
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